Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Aburahma, S. K.
Right arrow Articles by Amarin, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aburahma, S. K.
Right arrow Articles by Amarin, Z.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Botox
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Botulinum Toxin A Injections for the Treatment of Schwartz-Jampel Syndrome: A Case Series

Samah Khalil Aburahma, MD, ABPN

Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan, samahk@just.edu.jo

Taiseer Al-Khateeb, MScD

Faculty of Dentistry, Jordan University of Science and Technology, Irbid, Jordan

Ali Alrefai, MD, ABPN

Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

Zouhair Amarin, MD, FRCOG

Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

Schwartz-Jampel syndrome is a rare autosomal recessive disorder characterized by myotonia and skeletal dysplasia. Botulinum toxin A is emerging as a therapeutic option for patients with this syndrome. This study describes the use of botulinum toxin A in 4 children with Schwartz-Jampel syndrome. The response to this therapeutic modality was limited and variable.

Key Words: botulinum toxin • Schwartz-Jampel syndrome • myotonia

Journal of Child Neurology, Vol. 24, No. 1, 5-8 (2009)
DOI: 10.1177/0883073808320621
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?